• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

巨细胞颞动脉炎:一项重点关注不必要活检的临床病理研究。

Giant cell temporal arteritis: a clinicopathological study with emphasis on unnecessary biopsy.

作者信息

Alkatan Hind M, AlMana Fawziah, Maktabi Azza M Y

机构信息

Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

Department of Pathology, College of Medicine, King Saud University, Riyadh, Saudi Arabia.

出版信息

Front Ophthalmol (Lausanne). 2023 Dec 6;3:1327420. doi: 10.3389/fopht.2023.1327420. eCollection 2023.

DOI:10.3389/fopht.2023.1327420
PMID:38983072
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11182246/
Abstract

INTRODUCTION

Temporal artery (TA) biopsy is commonly used for the diagnosis of giant cell arteritis (GCA). However, a positive biopsy is no longer mandatory for diagnosis. This study aims to correlate the histopathological findings of TA biopsies in suspected cases of GCA to the clinical presentation in an ophthalmic tertiary eye care center to draw useful conclusions and advocate the possible implementation of guidelines for TA biopsy.

METHODS

Data was collected from patients' medical records including, demographics, clinical data, and histopathological findings and diagnosis. The 2022 American College of Rheumatology/ European Alliance of Associations for Rheumatology (ACR/EULAR) criteria have been used and partially adopted as a guide to compare the variables between TA biopsy-positive and negative groups as well as the TA biopsy-positive group and the group of patients with TA biopsy showing atherosclerosis.

RESULTS

Out of the total 35 patients who underwent a TA biopsy during the period of 23 years, 22.9% of patients had histopathological findings consistent with GCA and 42.9% had TA atherosclerotic changes, while the remaining 34.3% had histologically unremarkable TA. The mean age of all patients was 66 ± 10.9 years. Slightly more than half were females (54.3%) and the remaining were males (45.7%). In the group with positive TA biopsies, the mean age was 71 ± 8.4 years with a higher female predominance (female-to-male ratio of 5:3). The mean diagnostic clinical score used in our study was higher (7.5 ± 2.33) in the GCA-positive group when compared to the other groups with statistical significance (mean of 4.85 ± 2.01 in patients with overall GCA-negative biopsies and 5.13 ± 2.10 in the group with atherosclerosis). Other three clinical variables that were found to be statistically significant in the GCA biopsy-positive group were scalp tenderness, jaw claudication, and optic nerve pallor.

DISCUSSION

The mean age (71 ± 8.4 years) and the female predominance of GCA in our group of patients with positive TA biopsy (62.5%) was like other reports. In our study 22.9% of performed TA biopsies over the period of the study were positive confirming the diagnosis of GCA on histological exam, which was similar to another report and is considered to be relatively low. The incorporation of increased clinically focused assessments and algorithms, with the aid of the ACR/EULAR criteria, may decrease the frequency of TA biopsies that carries unnecessary cost and risk of procedure-related morbidity. We highly recommend applying the age of ≥ 50 years as an initial criterion for diagnosis, followed by the consideration of the statistically significant clinical features: scalp tenderness, jaw claudication, and optic nerve pallor.

摘要

引言

颞动脉(TA)活检常用于巨细胞动脉炎(GCA)的诊断。然而,活检结果呈阳性已不再是诊断的必要条件。本研究旨在将疑似GCA病例的TA活检组织病理学结果与眼科三级医疗中心的临床表现相关联,以得出有用的结论,并倡导可能实施的TA活检指南。

方法

从患者病历中收集数据,包括人口统计学、临床数据、组织病理学结果和诊断。采用并部分采用2022年美国风湿病学会/欧洲风湿病联盟(ACR/EULAR)标准作为指南,比较TA活检阳性和阴性组之间以及TA活检阳性组与TA活检显示动脉粥样硬化的患者组之间的变量。

结果

在23年期间接受TA活检的35例患者中,22.9%的患者组织病理学结果与GCA一致,42.9%有TA动脉粥样硬化改变,其余34.3%的TA组织学表现无异常。所有患者的平均年龄为66±10.9岁。略超过一半为女性(54.3%),其余为男性(45.7%)。在TA活检阳性组中,平均年龄为71±8.4岁,女性占比更高(男女比例为5:3)。与其他组相比,我们研究中使用的平均诊断临床评分在GCA阳性组中更高(7.5±2.33),具有统计学意义(总体GCA活检阴性的患者平均评分为4.85±2.01,动脉粥样硬化组平均评分为5.13±2.10)。在GCA活检阳性组中发现具有统计学意义的其他三个临床变量是头皮压痛、颌部跛行和视神经苍白。

讨论

我们TA活检阳性的患者组中GCA的平均年龄(71±8.4岁)和女性占优势(62.5%)与其他报告相似。在我们的研究中,在研究期间进行的TA活检中有22.9%呈阳性,在组织学检查中证实了GCA的诊断,这与另一篇报告相似,且被认为相对较低。借助ACR/EULAR标准纳入更多以临床为重点的评估和算法,可能会减少TA活检的频率,TA活检会带来不必要的成本和与手术相关的发病风险。我们强烈建议将≥50岁作为初始诊断标准,随后考虑具有统计学意义的临床特征:头皮压痛、颌部跛行和视神经苍白。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4424/11182246/ad05c71e44fc/fopht-03-1327420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4424/11182246/ad05c71e44fc/fopht-03-1327420-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4424/11182246/ad05c71e44fc/fopht-03-1327420-g001.jpg

相似文献

1
Giant cell temporal arteritis: a clinicopathological study with emphasis on unnecessary biopsy.巨细胞颞动脉炎:一项重点关注不必要活检的临床病理研究。
Front Ophthalmol (Lausanne). 2023 Dec 6;3:1327420. doi: 10.3389/fopht.2023.1327420. eCollection 2023.
2
Diagnosis of giant cell arteritis using clinical, laboratory, and histopathological findings in patients undergoing temporal artery biopsy.根据接受颞动脉活检的患者的临床、实验室和组织病理学发现诊断巨细胞动脉炎。
Clin Neurol Neurosurg. 2022 Oct;221:107377. doi: 10.1016/j.clineuro.2022.107377. Epub 2022 Jul 20.
3
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care.2022 年 ACR/EULAR 巨细胞动脉炎分类标准在常规临床护理中诊断疑似巨细胞动脉炎患者的性能。
RMD Open. 2023 Apr;9(2). doi: 10.1136/rmdopen-2022-002970.
4
Temporal Artery Biopsy for Diagnosing Giant Cell Arteritis: A Ten-year Review.颞动脉活检用于诊断巨细胞动脉炎:十年回顾
J Ophthalmic Vis Res. 2020 Apr 6;15(2):201-209. doi: 10.18502/jovr.v15i2.6738. eCollection 2020 Apr-Jun.
5
Temporal Artery Biopsy in the Workup of Giant Cell Arteritis: Diagnostic Considerations in a Veterans Administration Cohort.颞动脉活检在巨细胞动脉炎中的应用:退伍军人管理局队列中的诊断考虑因素。
J Neuroophthalmol. 2020 Dec;40(4):450-456. doi: 10.1097/WNO.0000000000001040.
6
Proposal to decrease the number of negative temporal artery biopsies.减少颞动脉活检阴性数量的提议。
Scand J Rheumatol. 2007 Mar-Apr;36(2):111-8. doi: 10.1080/03009740600991646.
7
Temporal headache and jaw claudication may be the key for the diagnosis of giant cell arteritis.颞部头痛和颌部间歇性运动障碍可能是巨细胞动脉炎诊断的关键。
Med Oral Patol Oral Cir Bucal. 2018 May 1;23(3):e290-e294. doi: 10.4317/medoral.22298.
8
Halo sign on temporal artery ultrasound versus temporal artery biopsy for giant cell arteritis.颞动脉超声的“晕征”与颞动脉活检在巨细胞动脉炎中的比较。
Cochrane Database Syst Rev. 2024 Feb 7;2(2):CD013199. doi: 10.1002/14651858.CD013199.pub2.
9
Baseline clinical predictors of an ultimate giant cell arteritis diagnosis in patients referred to temporal artery biopsy.转诊接受颞动脉活检的患者最终诊断为巨细胞动脉炎的基线临床预测因素。
Clin Rheumatol. 2016 Jul;35(7):1817-22. doi: 10.1007/s10067-016-3221-1. Epub 2016 Mar 1.
10
Temporal Arteritis Revealing Antineutrophil Cytoplasmic Antibody-Associated Vasculitides: A Case-Control Study.巨细胞动脉炎合并抗中性粒细胞胞质抗体相关性血管炎:一项病例对照研究。
Arthritis Rheumatol. 2021 Feb;73(2):286-294. doi: 10.1002/art.41527. Epub 2020 Dec 21.

引用本文的文献

1
Temporal Artery Biopsies: Understanding the Low Positivity Rate.颞动脉活检:解读低阳性率
Cureus. 2025 Apr 4;17(4):e81714. doi: 10.7759/cureus.81714. eCollection 2025 Apr.

本文引用的文献

1
External validation of the 2022 ACR/EULAR classification criteria in patients with suspected giant cell arteritis in a Dutch fast-track clinic.荷兰快速通道诊所中疑似巨细胞动脉炎患者中 2022 年 ACR/EULAR 分类标准的外部验证。
RMD Open. 2023 Jul;9(3). doi: 10.1136/rmdopen-2023-003080.
2
Performance of the 2022 ACR/EULAR giant cell arteritis classification criteria for diagnosis in patients with suspected giant cell arteritis in routine clinical care.2022 年 ACR/EULAR 巨细胞动脉炎分类标准在常规临床护理中诊断疑似巨细胞动脉炎患者的性能。
RMD Open. 2023 Apr;9(2). doi: 10.1136/rmdopen-2022-002970.
3
Temporal Artery Biopsy: When Is It Worth the Headache?
颞动脉活检:何时值得为之头痛?
WMJ. 2023 Mar;122(1):38-43.
4
Giant cell arteritis: reviewing the advancing diagnostics and management.巨细胞动脉炎:探索先进的诊断与管理。
Eye (Lond). 2023 Aug;37(12):2365-2373. doi: 10.1038/s41433-023-02433-y. Epub 2023 Feb 14.
5
Influence of the EULAR recommendations for the use of imaging in large vessel vasculitis in the diagnosis of giant cell arteritis: results of the ARTESER register.EULAR 推荐在巨细胞动脉炎诊断中使用影像学检查对大血管血管炎的影响:ARTESER 登记研究结果。
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002507.
6
2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis.2022 年美国风湿病学会/欧洲抗风湿病联盟巨细胞动脉炎分类标准。
Ann Rheum Dis. 2022 Dec;81(12):1647-1653. doi: 10.1136/ard-2022-223480. Epub 2022 Nov 9.
7
Temporal artery biopsy: A technical guide and review of its importance and indications.颞动脉活检:技术指南及其重要性与适应症综述
Surv Ophthalmol. 2023 Jan-Feb;68(1):104-112. doi: 10.1016/j.survophthal.2022.08.008. Epub 2022 Aug 20.
8
Mimickers of Large Vessel Giant Cell Arteritis.大血管巨细胞动脉炎的模仿者
J Clin Med. 2022 Jan 19;11(3):495. doi: 10.3390/jcm11030495.
9
Large-vessel vasculitis.大血管血管炎
Nat Rev Dis Primers. 2022 Jan 6;7(1):93. doi: 10.1038/s41572-021-00327-5.
10
Validation of a multimodal algorithm for diagnosing giant cell arteritis with imaging.使用影像学验证巨细胞动脉炎的多模态算法诊断。
Diagn Interv Imaging. 2022 Feb;103(2):103-110. doi: 10.1016/j.diii.2021.09.008. Epub 2021 Oct 16.